These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 21620029

  • 1. Donor-Model for End-Stage Liver Disease and donor-recipient matching in liver transplantation.
    Vitale A, Ramirez Morales R, dalla Bona E, Scopelliti M, Zanus G, Neri D, d'Amico F, Gringeri E, Russo F, Burra P, Angeli P, Cillo U.
    Transplant Proc; 2011 May; 43(4):974-6. PubMed ID: 21620029
    [Abstract] [Full Text] [Related]

  • 2. Low, rather than high, body mass index confers increased risk for post-liver transplant death and graft loss: Risk modulated by model for end-stage liver disease.
    Bambha KM, Dodge JL, Gralla J, Sprague D, Biggins SW.
    Liver Transpl; 2015 Oct; 21(10):1286-94. PubMed ID: 26097202
    [Abstract] [Full Text] [Related]

  • 3. Renal outcomes after liver transplantation in the model for end-stage liver disease era.
    Sharma P, Welch K, Eikstadt R, Marrero JA, Fontana RJ, Lok AS.
    Liver Transpl; 2009 Sep; 15(9):1142-8. PubMed ID: 19718633
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.
    Croome KP, Marotta P, Wall WJ, Dale C, Levstik MA, Chandok N, Hernandez-Alejandro R.
    Transplant Proc; 2012 Jun; 44(5):1303-6. PubMed ID: 22664005
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
    Hung K, Gralla J, Dodge JL, Bambha KM, Dirchwolf M, Rosen HR, Biggins SW.
    Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A, Volk ML, De Feo TM, Burra P, Frigo AC, Ramirez Morales R, De Carlis L, Belli L, Colledan M, Fagiuoli S, Rossi G, Andorno E, Baccarani U, Regalia E, Vivarelli M, Donataccio M, Cillo U, Liver Transplantation North Italy Transplant program (NITp) working group.
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [Abstract] [Full Text] [Related]

  • 12. Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching.
    Angelico M, Cillo U, Fagiuoli S, Gasbarrini A, Gavrila C, Marianelli T, Costa AN, Nardi A, Strazzabosco M, Burra P, Agnes S, Baccarani U, Calise F, Colledan M, Cuomo O, De Carlis L, Donataccio M, Ettorre GM, Gerunda GE, Gridelli B, Lupo L, Mazzaferro V, Pinna A, Risaliti A, Salizzoni M, Tisone G, Valente U, Rossi G, Rossi M, Zamboni F, Liver Match Investigators.
    Dig Liver Dis; 2011 Feb; 43(2):155-64. PubMed ID: 21185796
    [Abstract] [Full Text] [Related]

  • 13. Liver Transplantation for Hepatitis B in Early Adulthood: Analysis of the United Network for Organ Sharing Database.
    Rifai G, Anani A, Hanouneh IA, Mohamad B, Matloob A, Lopez R, Zein NN, Alkhouri N.
    Transplant Proc; 2016 Dec; 48(10):3362-3367. PubMed ID: 27931582
    [Abstract] [Full Text] [Related]

  • 14. D-MELD as a predictor of early graft mortality in adult-to-adult living-donor liver transplantation.
    Ikegami T, Imai D, Wang H, Yoshizumi T, Yamashita Y, Ninomiya M, Iguchi T, Bekki Y, Shirabe K, Maehara Y.
    Transplantation; 2014 Feb 27; 97(4):457-62. PubMed ID: 24531822
    [Abstract] [Full Text] [Related]

  • 15. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Nojiri K, Aoki T, Sakamoto Y, Hasegawa K, Koike K, Kokudo N.
    Transplant Proc; 2012 Mar 27; 44(2):389-92. PubMed ID: 22410024
    [Abstract] [Full Text] [Related]

  • 16. How can we utilize livers from advanced aged donors for liver transplantation for hepatitis C?
    Uemura T, Nikkel LE, Hollenbeak CS, Ramprasad V, Schaefer E, Kadry Z.
    Transpl Int; 2012 Jun 27; 25(6):671-9. PubMed ID: 22487509
    [Abstract] [Full Text] [Related]

  • 17. Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores.
    Chok KSh, Chan SC, Fung JY, Cheung TT, Chan AC, Fan ST, Lo CM.
    Hepatobiliary Pancreat Dis Int; 2013 Jun 27; 12(3):256-62. PubMed ID: 23742770
    [Abstract] [Full Text] [Related]

  • 18. Impact of MELD score implementation on liver allocation: experience at a Brazilian center.
    da Silva Machado AG, de Medeiros Fleck A, Marroni C, Zanotelli ML, Cantisani G, de Mello Brandão AB.
    Ann Hepatol; 2013 Jun 27; 12(3):440-7. PubMed ID: 23619261
    [Abstract] [Full Text] [Related]

  • 19. Survival outcomes in liver transplant recipients with Model for End-stage Liver Disease scores of 40 or higher: a decade-long experience.
    Panchal HJ, Durinka JB, Patterson J, Karipineni F, Ashburn S, Siskind E, Ortiz J.
    HPB (Oxford); 2015 Dec 27; 17(12):1074-84. PubMed ID: 26373873
    [Abstract] [Full Text] [Related]

  • 20. Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation.
    Vagefi PA, Ascher NL, Freise CE, Dodge JL, Roberts JP.
    Liver Transpl; 2012 Feb 27; 18(2):160-5. PubMed ID: 22006378
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.